3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
134
Breast Neoplasms
91
Neoplasms
8
Breast Neoplasms, Male
6
Neoplasm Metastasis
5
Advanced Breast Cancer
4
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Osteoporosis
2
Leiomyoma
2
Infertility
2
Advanced Prostate Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Radiation Injuries
1
Primary Ovarian Insufficiency
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Osteitis Deformans
1
Myofibroma
1
Lymphatic Metastasis
1
Kidney Diseases
1
Inflammatory Breast Neoplasms
1
Hypertension
1
Hyperlipidemias
1
Interventions
Acupuncture Therapy
10
Gabapentin
6
Venlafaxine Hydrochloride
4
Isoflavones
3
Estrogens, Conjugated (USP)
3
Bupivacaine
3
liposomal amphotericin B
2
fezolinetant
2
black cohosh root extract
2
Tamoxifen
2
Soybean Proteins
2
Sodium Chloride
2
Moxifloxacin
2
Magnesium Oxide
2
Hypnosis
2
Control Groups
2
Caspofungin
2
zopiclone
1
oxybutynin
1
bazedoxifene
1
Zolpidem
1
Vitamin B 6
1
Vancomycin
1
Therapeutics
1
Testosterone
1
Tazobactam
1
Tablets
1
Sugars
1
Solifenacin Succinate
1
Progesterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hot Flashes
×
Goserelin
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled